Related Experiment Videos

Periodic acid Schiff (PAS) positivity in fetal erythroblasts

G Carpani1, A Rosti, P Cori

  • 1Istituto di Scienze Biomediche, Università, Milano, Ospedale San Paolo, Italy.

Haematologica
|March 1, 1991
PubMed

Insights

Prenatal diagnosis using the PAS reaction on fetal blood smears revealed higher PAS-positive erythroblasts in abnormal cases. This suggests a link between fetal liver erythropoiesis and PAS positivity in erythroblasts.

Area of Science:

  • Perinatology
  • Hematology
  • Biochemistry

Background:

  • Prenatal diagnosis relies on accurate fetal assessments.
  • Erythroblastosis, an increase in immature red blood cells, can indicate fetal distress or abnormalities.
  • Periodic acid-Schiff (PAS) staining is a histochemical technique used to detect carbohydrates.

Purpose of the Study:

  • To investigate the correlation between PAS positivity in fetal blood erythroblasts and fetal abnormalities detected during prenatal diagnosis.
  • To explore the potential role of fetal liver erythropoiesis in PAS positivity.

Main Methods:

  • Fetal blood samples (n=26) from prenatal diagnoses were stained using the PAS reaction.
  • Samples were categorized as normal (n=12) or abnormal (n=14).
  • PAS positivity and erythroblast percentage were quantified and analyzed.

Main Results:

  • A high percentage of both normal (83.4%) and abnormal (92.8%) cases showed moderate PAS positivity.
  • Abnormal cases exhibited a significantly higher percentage of PAS-positive erythroblasts (p<0.01).
  • A moderate positive correlation was found between PAS positivity and erythroblastosis when all cases were pooled (r=0.536, p<0.005).

Conclusions:

  • Increased PAS-positive erythroblasts in fetal blood are associated with fetal abnormalities.
  • The findings suggest that the fetal hepatic environment and its erythropoiesis may contribute to PAS-positive erythroblasts.
  • PAS staining of fetal erythroblasts may serve as a potential biomarker in prenatal diagnosis.

Related Concept Videos